Clinical trial
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial…
NCT00141245 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00141245 |
|---|---|
| Title | To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. |
| Official title | Pregabalin Open-Label, Multicenter Add-On Trial Following a 4-Day Double-Blind Transition Period to Determine Long-Term Safety and Efficacy in Patients With Partial Seizures. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Seizure Disorder, Partial |
| Intervention type | Drug |
| Interventions | Pregabalin |
| Enrollment | 325 |
| Start date | Oct 1, 1998 |
| Completion | Nov 1, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Jan 1, 2007 |
| Countries | Australia, Austria, Belgium, Finland, France, Germany, Italy, Netherlands, South Africa, Spain, Sweden, Switzerland and 1 more |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: